Citation Impact

Citing Papers

CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
Plasmacytoid Dendritic Cell Dynamics and Alpha Interferon Production during Simian Immunodeficiency Virus Infection with a Nonpathogenic Outcome
2008 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients
2010
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Mechanisms of Thrombus Formation
2008 Standout
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
2008 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods
2002
Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage
1999
Male-to-female transmission of HIV in a cohort of hemophiliacs — Frequency, risk factors and effect of sexual counseling
1995
Guidelines on the investigation and management of antiphospholipid syndrome
2012
Antithrombotic Therapy for VTE Disease
2016 Standout
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Super-resolution microscopy demystified
2018 Standout
The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
2013 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Comparing hand‐held computers and paper diaries for haemophilia home therapy: a randomized trial
2004
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Dynamics and functions of lipid droplets
2018 Standout
Elevated CD38 Antigen Expression on CD8+ T Cells Is a Stronger Marker for the Risk of Chronic HIV Disease Progression to AIDS and Death in the Multicenter AIDS Cohort Study Than CD4+ Cell Count, Soluble Immune Activation Markers, or Combinations of HLA-DR and CD38 Expression
1997
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Chronic hepatitis B
2007 Standout
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV‐1‐infected patients
2004
T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy
2003
Chronic hepatitis B: Update 2009 #
2009 Standout
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
Misfolded proteins activate Factor XII in humans, leading to kallikrein formation without initiating coagulation
2008
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
The attitudes of health care staff to information technology: a comprehensive review of the research literature
2008
Laboratory diagnosis of the antiphospholipid syndrome
2002
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
A typology of reviews: an analysis of 14 review types and associated methodologies
2009 Standout
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
2020 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Molecular and cellular insights into T cell exhaustion
2015 Standout
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Antiphospholipid antibodies and pregnancy
2003
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection
2000
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Changes in thymic function with age and during the treatment of HIV infection
1998 StandoutNature
Applying systems-level spectral imaging and analysis to reveal the organelle interactome
2017 NatureNobel
Differential Upregulation of CD38 on Different T-Cell Subsets May Influence the Ability to Reconstitute CD4+ T Cells Under Successful Highly Active Antiretroviral Therapy
2005
Time-tagged ticker tapes for intracellular recordings
2023 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Infection of Primary Human Monocytes by Epstein-Barr Virus
2000
Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels during Follow-up
2008
Immune Function and Phenotype Before and After Highly Active Antiretroviral Therapy
1999
Antiretroviral Therapy Reduces Markers of Endothelial and Coagulation Activation in Patients Infected with Human Immunodeficiency Virus Type 1
2002
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Immune Function and Phenotype Before and After Highly Active Antiretroviral Therapy
2006
Trousseau's syndrome: multiple definitions and multiple mechanisms
2007
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation
2004
T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4 + T Cell Turnover
1996 Science
Naive T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy
2006 StandoutNobel
Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease
1997 StandoutScience
Understudied populations with hepatitis C
2002
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy
1998 StandoutNobel
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Thymocyte-Thymic Epithelial Cell Interaction Leads to High-Level Replication of Human Immunodeficiency Virus Exclusively in Mature CD4+CD8CD3+Thymocytes: a Critical Role for Tumor Necrosis Factor and Interleukin-7
1999 StandoutNobel
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
A substitution in the glutathione reductase lowers electron leakage and inflammation in modern humans
2022 StandoutNobel
Antigen-Dependent and -Independent Mechanisms of T and B Cell Hyperactivation during Chronic HIV-1 Infection
2011
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
A Critical and Comparative Review of Fluorescent Tools for Live-Cell Imaging
2016
In Vivo Neutrophil Dysfunction in Cirrhotic Patients with Advanced Liver Disease
2000
Intrinsic Pathway of Coagulation and Arterial Thrombosis
2007
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding
2011
Preventives Versus Treatments *
2015 StandoutNobel
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
2004

Works of Mark Winter being referenced

Visualization and correction of automated segmentation, tracking and lineaging from 5-D stem cell image sequences
2014
Computational Image Analysis Reveals Intrinsic Multigenerational Differences between Anterior and Posterior Cerebral Cortex Neural Progenitor Cells
2015
Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII
2000
Pilot study of an Internet‐based electronic patient treatment record and communication system for haemophilia, Advoy.com
2003
Increased number of primed activated CD8+CD38+CD45RO+T cells predict the decline of CD4+T cells in HIV-1-infected patients
1996
CD8+, CD38+ Lymphocyte Percent
1997
Increased bleeding associated with protease inhibitor therapy in HIV‐positive patients with bleeding disorders
1999
Assessment of phagocytic activity of granulocytes using laser flow cytometry
1989
Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia
2001
Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia
2001
Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis
2004
Venous thrombosis in inflammatory bowel disease
2005
Antibodies to factor XII and recurrent fetal loss in patients with the anti‐phospholipid syndrome
2001
The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant
2000
HTLV‐III antibody and T‐cell subset ratios in haemophiliacs and their spouses
1986
The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant
2000
LEVER: software tools for segmentation, tracking and lineaging of proliferating cells
2016
Rankless by CCL
2026